Molina Healthcare, Inc.: Form 10-Q for the period ended Sep 30, 2026
Filed with the SEC on Oct 22, 2026 and accepted by EDGAR at Oct 22, 2026, 13:23 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-07-01 to 2026-09-30 | $11.08bn | us-gaap:Revenues |
| Revenue | 9 months2026-01-01 to 2026-09-30 | $32.75bn | us-gaap:Revenues |
| Cost of revenue | 3 months2026-07-01 to 2026-09-30 | $9.72bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2026-01-01 to 2026-09-30 | $28.43bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months2026-07-01 to 2026-09-30 | $106.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2026-01-01 to 2026-09-30 | $334.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-07-01 to 2026-09-30 | $53.0m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2026-01-01 to 2026-09-30 | $161.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-07-01 to 2026-09-30 | $15.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2026-01-01 to 2026-09-30 | $61.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-07-01 to 2026-09-30 | $38.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2026-01-01 to 2026-09-30 | $112.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-07-01 to 2026-09-30 | $0.73 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2026-01-01 to 2026-09-30 | $2.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-07-01 to 2026-09-30 | $0.74 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2026-01-01 to 2026-09-30 | $2.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-07-01 to 2026-09-30 | 51,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2026-01-01 to 2026-09-30 | 51,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2026-01-01 to 2026-09-30 | $629.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2026-01-01 to 2026-09-30 | $94.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2026-01-01 to 2026-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-09-30 | $4.48bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-09-30 | $12.51bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-09-30 | $15.65bn | us-gaap:Assets |
| Current liabilities | At period end2026-09-30 | $7.39bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-09-30 | $11.50bn | us-gaap:Liabilities |
| Long-term debt | At period end2026-09-30 | $3.77bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2026-09-30 | $4.16bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001179929-26-000045. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.